# Testing the Effect of the InsuPad Device in Daily Life Conditions

Study · id `cardio:ct-nct01594801` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01594801](<https://clinicaltrials.gov/study/NCT01594801>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01594801

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.

## Technical summary

Registry record NCT01594801. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 145 participants (enrolled count; ClinicalTrials.gov record NCT01594801, source copy `cardio:ctgov-nct01594801-2013-03-13`, retrieved 2026-10-26)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT01594801, source copy `cardio:ctgov-nct01594801-2013-03-13`, retrieved 2026-10-26)
- Primary completion: 2013-02 (actual) (ClinicalTrials.gov record NCT01594801, source copy `cardio:ctgov-nct01594801-2013-03-13`, retrieved 2026-10-26)
- Completion: 2013-03 (actual) (ClinicalTrials.gov record NCT01594801, source copy `cardio:ctgov-nct01594801-2013-03-13`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT01594801, source copy `cardio:ctgov-nct01594801-2013-03-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01594801-2013-03-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Testing the Effect of the InsuPad Device in Daily Life Conditions
- Condition: Diabetics Mellitus Type 1
- Condition: Diabetes Mellitus Type 2
- Intervention (Device): InsuPad
- Lead sponsor: Insuline Medical Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus (`cardio:pubmed-24392996`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b62bfe26aae1b1beb83685f01c5a62542594e25eb6bfa6bc959a7caeb45f3b42
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
